Trial Details

RECRUITING
Basic Information
Clinical ID c1361
Identifier NCT05817942
Trial Title Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Filgotinib
Participant Information
Sponsor Alfasigma S.p.A.
City Graz
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2023-06-12
Primary Completion Date 2025-12-27
Completion Date 2025-12-27